BAUSCH FDA Approval NDA 021056

NDA 021056

BAUSCH

FDA Drug Application

Application #021056

Documents

Letter2000-06-28
Letter2011-04-13
Label2011-04-11
Review2001-07-12
Label2000-06-28

Application Sponsors

NDA 021056BAUSCH

Marketing Status

Prescription001

Application Products

001GEL;TOPICAL1%1TARGRETINBEXAROTENE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP2000-06-28PRIORITY
LABELING; LabelingSUPPL3AP2011-04-08UNKNOWN
MANUF (CMC); Manufacturing (CMC)SUPPL5AP2013-07-22PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL6AP2015-02-09PRIORITY

Submissions Property Types

ORIG1Orphan5
SUPPL3Null6
SUPPL5Null14
SUPPL6Null14

TE Codes

001PrescriptionAB

CDER Filings

BAUSCH
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21056
            [companyName] => BAUSCH
            [docInserts] => ["",""]
            [products] => [{"drugName":"TARGRETIN","activeIngredients":"BEXAROTENE","strength":"1%","dosageForm":"GEL;TOPICAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"04\/08\/2011","submission":"SUPPL-3","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/021056s003lbl.pdf\"}]","notes":""},{"actionDate":"06\/28\/2000","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2000\\\/21056lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"TARGRETIN","submission":"BEXAROTENE","actionType":"1%","submissionClassification":"GEL;TOPICAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2011-04-08
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.